SENSEX NIFTY

Us Food And Drug Administration

Sep 16, 2014 at 14:23 | Source: Moneycontrol.com
"Zydus Cadila has received tentative approval from the US Food and Drug Administration (US FDA) to market (anti-diabetic drug) Glipizide extended release tablets in the strength of 2.5 mg, 5 mg and 10 mg," said the company in its filing.
Sep 11, 2014 at 09:56 | Source: Moneycontrol.com
Sources say Sun Pharma was taken by surprise when a team of 5 inspectos of United States Food and Drug Administration (US FDA) walked in on Monday morning for inspection that is still ongoing.
Sep 01, 2014 at 12:08 | Source: Moneycontrol.com
Two drugs -- WCK 771 and WCK 2349 -- have received QIDP status, which allows fast-track review of the drug application by the US Food and Drug Administration (USFDA), Wockhardt said in a statement. This is the first instance of an Indian pharmaceutical company receiving QIDP status, it added.
Sep 01, 2014 at 11:06 | Source: CNBC-TV18
"Marketing partner in the USA, Mylan Inc has filed an abbreviated new drug application (ANDA) for a three-times-a-week generic Copaxone (glatiramer acetate injection, 40 mg/ml) and has been accepted by the US Food and Drug Administration (US FDA)," said the company in its filing.
Aug 31, 2014 at 19:07 | Source: PTI
Two drugs -- WCK 771 and WCK 2349 -- have received QIDP status, which allows fast-track review of the drug application by the US Food and Drug Administration (USFDA), Wockhardt said in a statement. This is the first instance of an Indian pharmaceutical company receiving QIDP status, it added.
Aug 26, 2014 at 15:25 | Source: Moneycontrol.com
According to a Quant report, most pharma companies continue to have strong ANDA filings pending for approval, which gives enough confidence of high long-term growth, subject to timely regulatory approval.
Aug 20, 2014 at 13:39 | Source: Moneycontrol.com
Zydus Cadila has received the final approval from the USFDA to market Acyclovir tablets in the strenths of 400 mg and 800 mg.
Aug 13, 2014 at 19:04 | Source: Moneycontrol.com
CRISIL Ratings has come out with its report on pharma. "Drug makers capex to surge 40% on sharper global focus, but despite the increase, credit quality is expected to remain stable", says the report.
Jul 24, 2014 at 12:57 | Source: Moneycontrol.com
After inspecting the companys active pharmaceutical ingredients (APIs) manufacturing unit at Raltam, US Food and Drug Administration (US FDA) has raised some concerns in Form 483. Hence the drug manufacturer will suspend shipments to the US markets till the issue is addressed.
Jul 22, 2014 at 09:39 | Source: CNBC-TV18
Currently 34 percent of Indocos sales come from exports, with 10 percent from the US.
Messages on Us Food And Drug Administration »

ahaslaltirm
a

Platinum Member

147 Followers

Wockhardt  

Jun 05, 2014, 04.15 PM IST | Source: PTI Wockhardt recalls 8712 hypertension drug bottles in US mkt According to US Food and Drug Administration (USFDA), Wockhardt USA Inc, a subsidiary of Mumbai-based firm is voluntarily recalling 8,712 bottles of the drug in the American market.

10.30 AM Jul 7th

Neha-Diwan

Platinum Member

812 Followers

Ranbaxy Labs  

Ranbaxy Laboratories Ltd has received approval from the US Food and Drug Administration (FDA) to launch a cheaper copy of Novartis AG`s blood pressure pill Diovan. Ranbaxy will be the first rival drug maker to launch a copy of Diovan in the United States and will be entitled to six months

10.20 AM Jun 30th

Amrita Gaba

New Member

416 Followers

Strides Arcolab  

Strides Arcolab has received regulatory approval to market a skin disease drug in the US. The US Food and Drug Administration (FDA) has allowed the company to sell Methoxsalen capsules of 10 mg strength, Bangalore-based Strides Arcolab said in a statement. The US market for generic Methoxsalen

12.33 PM Jun 9th

Willwin

Platinum Member

218 Followers

Wockhardt  

he U.S. Food and Drug Administration has expressed concerns over production processes at the U.S. unit of Wockhardt and there is a real possibility that its USA unit is banned by USFDA. If that happens the share will sink below 400. For the time being IMO,it will go down to 450-500 range.

10.16 AM May 29th

Willwin

Platinum Member

218 Followers

Wockhardt  

1.01 PM May 28th

Web Messenger

Platinum Member

239926 Followers

Wockhardt  

Source:NDTV Profit - Mumbai: The US Food and Drug Administration (FDA) has made some observations about the production process of the US unit of Indian generic drugmaker Wockhardt Ltd, the company said on Tuesday. The FDA last year banned Wockhardt's two Indian ...

7.12 PM May 27th

shakira9

New Member

2 Followers

Sun Pharma  

to increased scrutiny from regulators concerned that the quality of drugs made in that country aren’t up to US standards. The concerns prompted Margaret Hamburg, the commissioner of the US Food and Drug Administration (FDA), to go to India in February to meet with pharmaceutical makers there about production

12.14 PM May 15th

Web Messenger

Platinum Member

239926 Followers

News Now  

Source:Money Rediff News Report - New Delhi: India is launching a campaign to repair its reputation as a global supplier of cheap high-quality drugs, responding to bans imposed by US Food and Drug Administration (FDA) on several suppliers, two top officials said on Tuesday. As part of

2.34 PM May 7th

Web Messenger

Platinum Member

239926 Followers

News Now  

Source:Calcutta Telegraph News - New Delhi, May 6: Problems faced by Indian drug makers in the US are not related to quality but to documentation and data maintenance, a senior government official said today. Stressing that India is already engaged with the US Food and Drug Administration (USFDA

1.48 PM May 7th

arvinddhaka
d1987

New Member

0 Follower

Just Posted  

of Fall in the gearing level, Higher earnings growth, Removal of US Food and Drug Administration. We would like to assigned Buy rating to APL with a target price of Rs700 in one to two months.

6.33 PM Apr 23rd

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.